Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
Kips Bay Medical, Inc. (KIPS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/22/2015 |
8-K
| Quarterly results |
| 08/06/2015 |
8-K
| Quarterly results |
| 07/24/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/29/2015 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 05/12/2015 |
8-K
| Quarterly results |
| 03/24/2015 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...|
Docs:
|
"Form of Warrant to Purchase Shares of Common Stock of Kips Bay Medical, Inc. (Filed herewith)",
"Securities Purchase Agreement, among Kips Bay Medical, Inc. and the Investors party thereto (Filed herewith)",
"Registration Rights Agreement, among Kips Bay Medical, Inc. and the Investors party thereto (Filed herewith)",
"Employment Agreement, effective as of July 1, 2015, by and between Kips Bay Medical, Inc. and Manuel A. Villafaña (Filed herewith)",
"Kips Bay Medical Announces $3.25 Million Private Placement Bridge Financing" |
|
| 03/12/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 01/05/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/06/2014 |
8-K
| Quarterly results|
Docs:
|
"Kips Bay Medical Provides Feasibility Study Update and Reports Third Quarter 2014 Results MINNEAPOLIS, MN, November 6, 2014 – Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its third quarter ended September 27, 2014. Feasibility Study Update" |
|
| 10/23/2014 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 09/04/2014 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 08/12/2014 |
8-K
| Quarterly results|
Docs:
|
"Kips Bay Medical Provides Feasibility Study Update and Reports Second Quarter 2014 Results MINNEAPOLIS, MN, August 12, 2014 – Kips Bay Medical, Inc. , a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS ® Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its second quarter ended June 28, 2014. Enrollment Begins at Lenox Hill Hospital in New York" |
|
| 05/21/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/08/2014 |
8-K
| Quarterly results |
| 03/12/2014 |
8-K
| Quarterly results |
| 03/07/2014 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 02/05/2014 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 01/24/2014 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
| 01/17/2014 |
8-K
| Other Events |
| 11/07/2013 |
8-K
| Form 8-K - Current report |
| 09/06/2013 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 08/08/2013 |
8-K
| Quarterly results |
| 05/09/2013 |
8-K
| Quarterly results |
| 03/28/2013 |
8-K
| Quarterly results |
| 03/18/2013 |
8-K
| Other Events |
| 03/04/2013 |
8-K
| Entry into a Material Definitive Agreement |
| 12/26/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/13/2012 |
8-K
| Quarterly results|
Docs:
|
"Kips Bay Medical Provides FDA Update and Reports Third Quarter 2012 Results Minneapolis, MN, November 13, 2012 —Kips Bay Medical, Inc. along with Manny Villafaña, its Founder, Chairman and CEO, provides an FDA update and announces financial results for its third quarter ended September 29, 2012. FDA Update On November 8, 2012, the Company announced that the United States Food and Drug Administration has granted conditional approval of Kips Bay Medical's Investigational Device Exemption to include four U.S. study sites in the “eMESH I” clinical feasibility trial of its eSVS® Mesh. The Company is currently working through the internal review and approval process with a number of leading cardiac centers in the United States. The eMESH I clinical feasibility trial is a multi-center, rando..." |
|
| 11/08/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
| 09/10/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/22/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
| 08/09/2012 |
8-K
| Quarterly results|
Docs:
|
"Kips Bay Medical Provides FDA Update and Reports Second Quarter 2012 Results Minneapolis, MN, August 9, 2012 —Kips Bay Medical, Inc. today provides an FDA update and announces financial results for its second quarter ended June 30, 2012. FDA Update As previously announced on July 18, 2012, Kips Bay Medical filed an application for an Investigational Device Exemption with the U.S. Food & Drug Administration to include four U.S. sites in the “eMESH I” clinical feasibility study of its innovative eSVS® Mesh device currently being pursued in Europe. As of the date of this press release, a number of leading cardiac centers in the U.S. have already expressed an interest in participating in the eMESH I study, pending FDA approval of the IDE. The eSVS Mesh is a highly flexible, kink-resistant tubu..." |
|
| 08/02/2012 |
8-K
| Form 8-K - Current report |
| 07/18/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
|
|
|